Collaboration is key as biopharma firms speed up their response to demands for innovation

Nov 25, 2021
Robert Marcus

Related news

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture (ACN) Announces Strategic Investment in Geneyx

Sep 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Venture capitalists raise more than $100bn to target life sciences

Feb 26
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Can tech for good be as profitable as plain old tech?

Sep 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gates Foundation pours cash into British firm Exscientia to fight pandemics

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Bridging the ESG Valley of Death

Sep 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Jeito extends global reach in oversubscribed $625M venture fund

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Bridging the ESG Valley of Death

May 10
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Oct 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Big-name U.S. tech investors are moving in on Europe in increasing numbers

Nov 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Our Relationship with AI: Friend Or Foe? Summary of our Global Study

Sep 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report

Nov 8
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Filings buzz in pharmaceuticals: 24% increase in artificial intelligence mentions in Q2 2021